The store will not work correctly when cookies are disabled.
1-(3-fluoro-4-(4-(4-fluorobenzoyl)piperazin-1-yl)phenyl)ethanone
ID: ALA4872245
PubChem CID: 697890
Max Phase: Preclinical
Molecular Formula: C19H18F2N2O2
Molecular Weight: 344.36
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)c1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2)c(F)c1
Standard InChI: InChI=1S/C19H18F2N2O2/c1-13(24)15-4-7-18(17(21)12-15)22-8-10-23(11-9-22)19(25)14-2-5-16(20)6-3-14/h2-7,12H,8-11H2,1H3
Standard InChI Key: GTODBMTUYFVLJS-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
31.6255 -1.9852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6244 -2.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3324 -3.2137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0421 -2.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0393 -1.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3306 -1.5763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9199 -3.2105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2127 -2.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5068 -3.2037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5019 -4.0212 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2091 -4.4325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9212 -4.0264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9177 -1.5767 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.7454 -1.5703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4547 -1.9762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7424 -0.7531 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.7923 -4.4266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0865 -4.0147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7886 -5.2438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0937 -3.1996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3887 -2.7878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6781 -3.1932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6770 -4.0147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3826 -4.4227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9717 -2.7824 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
2 7 1 0
1 13 1 0
5 14 1 0
14 15 1 0
14 16 2 0
10 17 1 0
17 18 1 0
17 19 2 0
18 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 18 1 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.36 | Molecular Weight (Monoisotopic): 344.1336 | AlogP: 3.13 | #Rotatable Bonds: 3 |
Polar Surface Area: 40.62 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.85 | CX LogD: 2.85 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.80 | Np Likeness Score: -1.66 |
References
1. (2020) Inhibitors of GPR174 and Uses Thereof, |
2. (2020) Methods and Compositions for Treating Cancer, |